Compare efficacy and safety of alpha1-blockers in patients with benign prostatic hyperplasia

Not Applicable

• Conditions: Benign Prostatic Hyperplasia

• Registration Number: JPRN-UMIN000010198
• Lead Sponsor: Matsushita Urologocal Clinic

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-03-11
• Study Completion: 2014-09-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: Male
• Target Recruitment: 70

Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients who have taken a medicine that influence on the urination function. 2)Patients with suspected prostate cancer. 3)Patients with suspected Neurogenic Bladder. 4)Patients with urethral stricture. 5)Patients who gave radiotherapy in the pelvis. 6)Patients with urinary tract infection, calculus urinary, cystitis interstitial. 7)Patients with serious impaired liver function, serious renal dysfunction, serious heart disorder. 8)Patients with orthostatic hypotension. 9)Patients with myasthenia gravis. 10)Maximum urinary flow rate=>15mL/s 11)The inappropriate patients who is judged by urologist.

Study & Design

• Study Type: Interventional
• Study Design: Not specified